Hyperglycemia treatment market research and analysis by treatment, mode of administration, end user - global forecast till 2030. A disease known as hyperglycemia is brought on by elevated blood glucose (blood sugar) levels. Diabetes, comprising both type 1 and type 2 diabetes, is indicated by hyperglycemia. One of the treatments for people with type 1 diabetes is insulin therapy.
Almost 60 million individuals in the European region have diabetes, and the prevalence is rather high in people older than 25 years, according to the World Health Organization. Obesity, a poor diet, and a lack of exercise are the key contributors, and these factors also indirectly fuel market expansion.
The market is expanding as a result of factors such as rising diabetes prevalence, increased desire for better treatments, rising RD spending in the biotechnology and pharmaceutical industries, and funding availability. In addition, rising government funding for RD, shifting lifestyles, and quickly evolving technology are anticipated to drive market expansion throughout the projection period. However, throughout the years 2022–2030, high treatment costs could restrain market expansion.
The global hyperglycemia treatment market is expected to grow at a CAGR of 10.40 % during the forecast period 2022-2030.
Key Players
Some of key the players in the market are Novo Nordisk A/S, Merck Company Inc., Medtronic, Johnson Johnson Services, Inc. , Teva Pharmaceuticals Ltd., Eli Lilly and Company, Sanofi S.A., Home Diagnostics, Bayer AG, Bristol-Myers Squibb., and Abbott.
Segmentation
The global hyperglycemia treatment market report has been segmented on the basis of treatment, mode of administration and end user.
On the basis of treatment, it is segmented into fluid replacement, electrolyte replacement, insulin therapy, and drugs. The drugs segment is further classified into sulfonylureas, biguanides, thiazolidinediones, and others.
On the basis of mode of administration, it is segmented into topical, oral, and others.
On the basis of end user, the market is segmented into hospitals clinics, pharmacy, and others.
Regional Analysis
The Americas dominates the global hyperglycemia treatment market owing to the presence of huge patient population with diabetes, neurological disorder, high healthcare spending, and increasing government support for research development.
Europe holds the second largest share of the global hyperglycemia treatment market as result of increasing focus of various government agencies on the treatment of hyperglycemia and cardiovascular diseases. Moreover, the growing public awareness about hyperglycemia likely to boost the adoption of these devices in the Europe market.
According to the World Health Organization, about 60 million people have diabetes in the European Region. The stats also suggests that about 10.3% of men and 9.6% of women are aged 25 years and over have diebetes.
Asia Pacific is the fastest growing hyperglycemia treatment market across the globe. Japan holds the major share of the regional market due to availability of advanced technology and huge healthcare spending. Moreover, rapidly developing economy, increasing healthcare expenditure, and the governments initiatives for research development projected to drive the market in China and India over the forecasted period.
The Middle East and Africa holds the least share of the global market due to limited availability of medical facilities. The UAE, Saudi Arabia, and Kuwait are expected to drive the Middle East African market. Whereas, the African region is expected to witness a moderate growth.
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Contact Us:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: sales@marketresearchfuture.com
Website: https://www.marketresearchfuture.com
